Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement

Parag Goyal1, Robert J Didomenico2, Susan J Pressler3

  • 1Program for the Care and Study of the Aging Heart, Department of Medicine, Weill Cornell Medicine, New York, NY.

PubMed

Insights

Cognitive impairment is common in heart failure (HF) patients, impacting self-care and prognosis. Early identification and integrated management are crucial for improving patient outcomes and quality of life.

Area of Science:

  • Cardiology
  • Neurology
  • Geriatrics

Background:

  • Heart failure (HF) frequently co-occurs with cognitive impairment in adults.
  • Aging and multimorbidity are significant risk factors for both conditions.
  • HF pathophysiology can directly affect brain function.

Purpose of the Study:

  • To highlight the prevalence and implications of cognitive impairment in heart failure patients.
  • To guide clinicians in identifying and managing cognitive deficits in HF.
  • To emphasize the integration of cognitive assessment into HF care.

Main Methods:

  • Review of existing literature and clinical evidence.
  • Identification of clinical clues for cognitive impairment in HF encounters.
  • Recommendations for screening tools (e.g., Mini-Cog) and neurocognitive testing referrals.

Main Results:

  • Cognitive impairment significantly affects HF self-care, medication adherence, functional independence, and survival.
  • Clinicians can identify suggestive signs during patient assessments.
  • Screening and comprehensive testing are indicated for suspected cognitive impairment.

Conclusions:

  • Management strategies include addressing underlying causes, optimizing medications, and supporting self-care deficits.
  • Integrating cognitive impairment into clinical decision-making is essential for comprehensive HF care.
  • This statement provides guidance for managing this complex patient subgroup.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
584
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
338
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K